Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Tianyi Pharmaceutical Holdings, Inc., operating primarily through its subsidiary Hubei Tianyi Pharmaceutical, is a China-based pharmaceutical company focused on the development and production of Traditional Chinese Medicine (TCM) and generic pharmaceuticals. The company’s extensive product portfolio includes treatments for cardiovascular, respiratory, and digestive conditions, as well as anti-inflammatory medications. Its flagship products are often listed on China's National Essential Drugs List, ensuring a broad market reach within the domestic healthcare system. With manufacturing facilities located in Hubei Province, the company maintains GMP-certified production lines for various dosage forms including tablets, capsules, and granules. Historically, the company has sought to capitalize on the modernization of the TCM market by integrating western pharmacological standards with traditional formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Tianyi Pharmaceutical.